Ary Serpa Neto, Tomoko Fujii, Mairead McNamara, James Moore, Paul J Young, Sandra Peake, Michael Bailey, Carol Hodgson, Alisa M Higgins, Emily J See, Paul Secombe, Lewis Campbell, Meredith Young, Mikihiro Maeda, David Pilcher, Alistair Nichol, Adam Deane, Elisa Licari, Kyle White, Craig French, Yahya Shehabi, Anthony Cross, Matthew Maiden, Umesh Kadam, Khaled El Khawas, Jamie Cooper, Rinaldo Bellomo, Andrew Udy
OBJECTIVES: To identify the best population, design of the intervention, and to assess between-group biochemical separation, in preparation for a future phase III trial. DESIGN: Investigator-initiated, parallel-group, pilot randomized double-blind trial. SETTING: Eight ICUs in Australia, New Zealand, and Japan, with participants recruited from April 2021 to August 2022. PATIENTS: Thirty patients greater than or equal to 18 years, within 48 hours of admission to the ICU, receiving a vasopressor, and with metabolic acidosis (pH < 7...
November 1, 2023: Critical Care Medicine